Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Glamour Shots once ruled the mall. I went to one of the last ones standing. - 2These Are the Journalists Israel Has Killed Since the Start of the Iran War
- 3Tech for Wellbeing: Applications and Devices for a Better You
- 4Air travelers face higher ticket prices as Iran war drives up oil prices
- 5Experience Sports in Dubai: A Daredevil's Aide
- ‘Raising 10 red flags’: Is Israel’s army exhausted?
- Illumina unveils dataset to speed up AI-powered drug discovery
- Which Instax Camera Would it be a good idea for you to Purchase?
- Exploring the Gig Economy: Illustrations from Consultants
- The Tiny Channel Island With 65 Residents That Chefs And Foodies Go Out Of Their Way To Visit
- A somber Thor is returning for 'Avengers: Doomsday': Watch the dread-filled teaser
- Instructions to Augment the Presentation of Your Kona SUV
- Select Your Go-To Bluetooth Earphones
- FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
